Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies
Inge Verbrugge, Jim Hagekyriakou, Leslie L Sharp, Mara Galli, Alison West, Nicole M McLaughlin, Helene Duret, Hideo Yagita, Ricky W Johnstone, Mark J Smyth, Nicole M Haynes
Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2012
Awarded by Dutch Cancer Society
This work was financially supported by the Dutch Cancer Society to I. Verbrugge (NKI2009-4446); National Health and Medical Research Council of Australia (NHMRC) program grants, Susan G. Komen Breast Cancer Foundation, Victorian Cancer Agency (to M.J Smyth and R. W Johnstone); Victorian Breast Cancer Research Consortium (to R. W. Johnstone, M.J. Smyth, and N.M. Haynes); Leukemia Foundation of Australia, Australian Rotary Health Foundation (to R. W. Johnstone); an NHMRC Fellowship (to M.J. Smyth); Pfizer, Cancer Australia and a Cure Cancer Australia grant (to N.M. Haynes).